PVCT Exercise Disclosure
Pershing Edward · SEC Form 4 · Filed Oct 5, 2026
Exercise
Reported value range
Not reported
Pershing Edward CEO
PVCT
Transaction date
Oct 3, 2026
Public filing date
Oct 5, 2026
Filing lag
Filed 2 days later
PVCT daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- 8% Unsecured Convertible Promissory Note on Series D-1 Convertible Preferred Stock
- Quantity / price
- Derivative security
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-045713
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Provectus Biopharmaceuticals, Inc. PVCT Current | Exercise | Oct 3, 2026 | Not reported |
| Provectus Biopharmaceuticals, Inc. PVCT | Exercise | Oct 3, 2026 | $0 |